Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CB1 and GLP-1 Receptors Cross Talk Provides New Therapies for Obesity
Philippe Zizzari, Rongjun He, Sarah Falk, et al.
Diabetes (2020) Vol. 70, Iss. 2, pp. 415-422
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Glucagon-like Peptide-1 Receptor-based Therapeutics for Metabolic Liver Disease
Julian M. Yabut, Daniel J. Drucker
Endocrine Reviews (2022) Vol. 44, Iss. 1, pp. 14-32
Open Access | Times Cited: 75
Association of semaglutide with reduced incidence and relapse of cannabis use disorder in real-world populations: a retrospective cohort study
William Yang Wang, Nora D. Volkow, Nathan A. Berger, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 8, pp. 2587-2598
Open Access | Times Cited: 24
The future of incretins in the treatment of obesity and non-alcoholic fatty liver disease
Christine R. Andreasen, Andreas Andersen, Tina Vilsbøll
Diabetologia (2023) Vol. 66, Iss. 10, pp. 1846-1858
Open Access | Times Cited: 27
Pharmacotherapy of obesity: An update
Andrea Cignarella, Luca Busetto, Roberto Vettor
Pharmacological Research (2021) Vol. 169, pp. 105649-105649
Closed Access | Times Cited: 38
(Wh)olistic (E)ndocannabinoidome-Microbiome-Axis Modulation through (N)utrition (WHEN) to Curb Obesity and Related Disorders
Jyoti Sihag, Vincenzo Di Marzo
Lipids in Health and Disease (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 24
Nutrition, endocannabinoids, and the use of cannabis: An overview for the nutrition clinician
Lindsey Russell, Kayla Condo, Tiffany DeFlorville
Nutrition in Clinical Practice (2024) Vol. 39, Iss. 4, pp. 815-823
Open Access | Times Cited: 5
Seventeen years since rimonabant's downfall: reassessing its suicidality risk profile
Yuval Cohen, Andrew Kolodziej, Marshall Morningstar
Obesity (2024) Vol. 32, Iss. 7, pp. 1235-1244
Open Access | Times Cited: 5
Olfaction in the context of obesity and diabetes: Insights from animal models to humans
Maya Faour, Chr̀istophe Magnan, Hirac Gurden, et al.
Neuropharmacology (2021) Vol. 206, pp. 108923-108923
Open Access | Times Cited: 31
Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003–2017: part 3 – spatiotemporal, multivariable and causal inferential pathfinding and exploratory analyses of prostate and ovarian cancers
Albert Stuart Reece, Gary Kenneth Hulse
Archives of Public Health (2022) Vol. 80, Iss. 1
Open Access | Times Cited: 22
A GLP‐1/glucagon (GCG)/CCK2 receptors tri‐agonist provides new therapy for obesity and diabetes
Songfeng Zhao, Zhiming Yan, Yue Du, et al.
British Journal of Pharmacology (2022) Vol. 179, Iss. 17, pp. 4360-4377
Open Access | Times Cited: 21
Olivetol’s Effects on Metabolic State and Gut Microbiota Functionality in Mouse Models of Alimentary Obesity, Diabetes Mellitus Type 1 and 2, and Hypercholesterolemia
Anastasia A. Zabolotneva, K. E. Popruga, В. В. Макаров, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 183-183
Open Access
A Combined GLP-1/PPARa/CB1-Based Therapy to Restore theCentral and Peripheral Metabolic Dysregulation Induced by a High-Fructose High-Fat Diet
Marialuisa de Ceglia, Nabila Rasheed, Rubén Tovar, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2420-2420
Open Access
Targeting the Endocannabinoidome: A Novel Approach to Managing Extraintestinal Complications in Inflammatory Bowel Disease
Dinesh Thapa, Anshu Ghimire, Leon N. Warne, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 478-478
Open Access
The NLRP3 inhibitor NT‐0796 enhances and sustains GLP‐1R agonist‐mediated weight loss in a murine diet‐induced obesity model
Peter Thornton, Valérie Reader, Zsofia Digby, et al.
Obesity (2025)
Open Access
Geospatiotemporal and causal inference study of cannabis and other drugs as risk factors for female breast cancer USA 2003–2017
Albert Stuart Reece, Gary Kenneth Hulse
Current Zoology (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 17
Poly-Agonist Pharmacotherapies for Metabolic Diseases: Hopes and New Challenges
C. Allard, Daniela Cota, Carmelo Quarta
Drugs (2023) Vol. 84, Iss. 2, pp. 127-148
Closed Access | Times Cited: 6
Novel cannabinoid receptor 1 inverse agonist CRB‐913 enhances efficacy of tirzepatide, semaglutide, and liraglutidein the diet‐induced obesity mouse model
Marshall Morningstar, Andrew Kolodziej, Suzie A. Ferreira, et al.
Obesity (2023) Vol. 31, Iss. 11, pp. 2676-2688
Open Access | Times Cited: 4
Endocannabinoid-related molecules predict the metabolic efficacy of GLP-1 receptor agonism in humans with obesity
Isabel Matias, Elizabeth Lehmann, Philippe Zizzari, et al.
Journal of Endocrinological Investigation (2023) Vol. 47, Iss. 5, pp. 1289-1294
Closed Access | Times Cited: 4
G protein-coupled receptors and obesity
Alessandro Pocai
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 3
Δ9-Tetrahydrocannabinol Treatment Modifies Insulin Secretion in Pancreatic Islets from Prediabetic Mice Under Hypercaloric Diet
Guadalupe M. Garcia-Luna, Juan David Bermudes-Contreras, Samantha Hernández-Correa, et al.
Cannabis and Cannabinoid Research (2023) Vol. 9, Iss. 5, pp. 1277-1290
Closed Access | Times Cited: 2
CB1 Ligand AM251 Induces Weight Loss and Fat Reduction in Addition to Increased Systemic Inflammation in Diet-Induced Obesity
Lannie O’Keefe, Teresa Vu, Anna Simcocks, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11447-11447
Open Access | Times Cited: 4
Caloric restriction, physical exercise, and CB1 receptor blockade as an efficient combined strategy for bodyweight control and cardiometabolic status improvement in male rats
Luisa M. Lopez Trinidad, Rosario Martínez, Garyfallia Kapravelou, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 5
A Combination of Glucagon-Like Peptide-1 Receptor Agonist and Dietary Intervention Could Be a Promising Approach for Obesity Treatment
Chooi Yeng Lee
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 4
Maternal obesity changes the small intestine endocannabinoid system and fecal metabolites of weanling rats associated with reduced intestinal permeability and impaired glucose homeostasis
Mariana M. Almeida, Camila Calviño, Clara F. Reis-Gomes, et al.
The Journal of Nutritional Biochemistry (2024) Vol. 136, pp. 109802-109802
Closed Access
TGR5 receptors in SF1-expressing neurons of the ventromedial hypothalamus regulate glucose homeostasis
Philippe Zizzari, Ashley Castellanos-Jankiewicz, Selma Yagoub, et al.
Molecular Metabolism (2024) Vol. 91, pp. 102071-102071
Open Access
Page 1 - Next Page

Scroll to top